Landec (LNDC) Tops Q3 EPS by 1c, Revenues Miss; Offers Q1 EPS/Revenue Guidance Below Consensus, FY19 EPS Views Below Consensus

Go back to Landec (LNDC) Tops Q3 EPS by 1c, Revenues Miss; Offers Q1 EPS/Revenue Guidance Below Consensus, FY19 EPS Views Below Consensus

Landec Corporation Reports Third Quarter and First Nine Months Fiscal 2019 Results

April 3, 2019 4:05 PM EDT

SANTA CLARA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a leading innovator of diversified health and wellness solutions with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc. reported results for the fiscal 2019 third quarter and first nine months ended February 24, 2019. 

During the third quarter we made significant progress in our strategic objectives to drive long-term shareholder value. Lifecore completed the installation of its new multi-purpose vial and syringe filling line in preparation for commercial production of vials that is expected to begin on the new line... More